Oncology
Forschungsbereich der Onkologie
Molekulare Mechanismen von Krebserkrankungen zu entdecken und passende Wirkstoffe zu identifizieren stellen wichtige Teilbereiche in der Krebsforschung dar.
Die Tumordiversität ist sehr hoch. Dementsprechend gehört die Krebsforschung zu einem der vielfältigsten Forschungsbereiche und umfasst viele wissenschaftliche Ansätze.
Wir bieten Ihnen deshalb eine konkurrenzlose Produktvielfalt für die onkologische Forschung und Entwicklung im akademischen sowie pharmazeutischen Bereich an.
Klicke auf die Organe und erfahre mehr über verschiedene Krebsarten
Allgemeine Informationen
Onkologen befassen sich mit der Diagnose, Therapie und Nachsorge von Krebs.
Krebs ist eine Klasse von Krankheiten, bei der sich entartete Zellen unkontrolliert teilen und in andere Gewebe eindringen können. Krebszellen können sich über das Blut- und Lymphsystem auf andere Teile des Körpers ausbreiten. Normalerweise wird die Zellproliferation durch viele Mechanismen streng kontrolliert. Darüber hinaus ist das Immunsystem in der Lage, Krebszellen zu erkennen und zu zerstören.
Funktionieren diese Mechanismen nicht richtig oder das Immunsystem kann die Zellen nicht effektiv zerstören, kann es zu einem malignen Tumor kommen. Eine bösartige Neoplasie ist theoretisch überall möglich, es gibt jedoch Krebsarten, die häufiger vorkommen als andere. Bei Männern ist die Prostata und bei Frauen die Brustdrüse die häufigste Tumorlokalisation.
Relevante Produkte für die onkologische Forschung
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Monoclonal Antibody to Titin (TTN) | Anmelden | Monoclonal Antibody to Titin (TTN) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Cluster Of Differentiation 146 (CD146) | Anmelden | Monoclonal Antibody to Cluster Of Differentiation 146 (CD146) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Protein Kinase, AMP Activated Beta 1 (PRKAb1) | Anmelden | Monoclonal Antibody to Protein Kinase, AMP Activated Beta 1 (PRKAb1) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Insulin Like Growth Factor Binding Protein 7 (IGFBP7) | Anmelden | Monoclonal Antibody to Insulin Like Growth Factor Binding Protein 7 (IGFBP7) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Melanotransferrin (MFI2) | Anmelden | Monoclonal Antibody to Melanotransferrin (MFI2) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Duffy Blood Group Chemokine Receptor (DARC) | Anmelden | Monoclonal Antibody to Duffy Blood Group Chemokine Receptor (DARC) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Suppressors Of Cytokine Signaling 3 (SOCS3) | Anmelden | Monoclonal Antibody to Suppressors Of Cytokine Signaling 3 (SOCS3) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to B-Cell Activating Factor (BAFF) | Anmelden | Monoclonal Antibody to B-Cell Activating Factor (BAFF) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Permeability Glycoprotein (Pgp) | Anmelden | Monoclonal Antibody to Permeability Glycoprotein (Pgp) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Myogenic Differentiation (MyoD) | Anmelden | Monoclonal Antibody to Myogenic Differentiation (MyoD) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Hedgehog Homolog, Sonic (SHH) | Anmelden | Monoclonal Antibody to Hedgehog Homolog, Sonic (SHH) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Complement Factor D (CFD) | Anmelden | Monoclonal Antibody to Complement Factor D (CFD) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Interleukin 2 Receptor Alpha (IL2Ra) | Anmelden | Monoclonal Antibody to Interleukin 2 Receptor Alpha (IL2Ra) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Small Breast Epithelial Mucin (SBEM) | Anmelden | Monoclonal Antibody to Small Breast Epithelial Mucin (SBEM) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Inhibitory Subunit Of NF Kappa B Alpha (IkBa) | Anmelden | Monoclonal Antibody to Inhibitory Subunit Of NF Kappa B Alpha (IkBa) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Glutamate Receptor Interacting Protein 1 (GRIP1) | Anmelden | Monoclonal Antibody to Glutamate Receptor Interacting Protein 1 (GRIP1) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Neuregulin 1 (NRG1) | Anmelden | Monoclonal Antibody to Neuregulin 1 (NRG1) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Receptor Tyrosine Protein Kinase erbB-2 (ErbB2) | Anmelden | Monoclonal Antibody to Receptor Tyrosine Protein Kinase erbB-2 (ErbB2) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Xeroderma Pigmentosum, Complementation Group G (XPG) | Anmelden | Monoclonal Antibody to Xeroderma Pigmentosum, Complementation Group G (XPG) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Cluster Of Differentiation 3d (CD3d) | Anmelden | Monoclonal Antibody to Cluster Of Differentiation 3d (CD3d) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Cluster Of Differentiation 19 (CD19) | Anmelden | Monoclonal Antibody to Cluster Of Differentiation 19 (CD19) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Bone Marrow Stromal Cell Antigen 2 (BST2) | Anmelden | Monoclonal Antibody to Bone Marrow Stromal Cell Antigen 2 (BST2) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Growth Differentiation Factor 15 (GDF15) | Anmelden | Monoclonal Antibody to Growth Differentiation Factor 15 (GDF15) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to S100 Calcium Binding Protein A7 (S100A7) | Anmelden | Monoclonal Antibody to S100 Calcium Binding Protein A7 (S100A7) | ||||||||||||||||
|
||||||||||||||||||
| Monoclonal Antibody to Peroxisome Proliferator Activated Receptor Delta (PPARd) | Anmelden | Monoclonal Antibody to Peroxisome Proliferator Activated Receptor Delta (PPARd) | ||||||||||||||||
|
||||||||||||||||||


